DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Durect Corporation (DRRX)
« Back to company indexDRRX Chatter Timeline
Stock Ticker for DRRX
Most Active Tweeters for DRRX
| User | Tweets |
|---|---|
| @bibeypost_stock | 2 |
| @Jaldip15 | 2 |
| @AmericanBanking | 2 |
| @ConsumerFeed | 1 |
| @mmahotstuff1 | 1 |
Recent Tweets for DRRX
 |
@AmericanBanking DURECT Co. $DRRX Expected to Post Quarterly Sales of $3.50 Million https://t.co/NC2FztYZXE #stocks April 19th 2019, 3:04am |
 |
@Jaldip15 $DRRX update from today’s meeting ? April 17th 2019, 3:04pm |
|
@AmericanBanking -$0.05 EPS Expected for DURECT Co. $DRRX This Quarter https://t.co/txZmUMe4sH #stocks April 17th 2019, 2:04pm |
|
@Jaldip15 $DRRX still holding. April 16th 2019, 10:04am |
 |
@bibeypost_stock Durect Corporation $DRRX Sellers Increased By 0.57% Their Shorts https://t.co/KtyYtAtNsP April 15th 2019, 6:04am |
|
@bibeypost_stock Durect Corp's $DRRX Sentiment is 0.89 https://t.co/ryxqVYeq9r April 13th 2019, 2:04pm |
 |
@ConsumerFeed DURECT Co. $DRRX Stake Lowered by Ingalls & Snyder LLC https://t.co/KxyeW8arVk April 12th 2019, 4:04am |
 |
@autisticnation1 This endogenous #exosterol could be worth billions for $drrx. It is so versatile, hardly any ae, works in low doses… https://t.co/q4Xhv7mitL April 10th 2019, 4:04pm |
 |
@4thQuarterCap Added to $DRRX https://t.co/HZlverYhL4 April 8th 2019, 8:04pm |
 |
@LlcBillionaire $DRRX strong squeeze coming here April 7th 2019, 2:04pm |
 |
@mmahotstuff1 Durect Corporation $DRRX Could Burn Your Long Portfolio After More Shorts https://t.co/twgo9OGJMR April 7th 2019, 10:04am |
 |
@TopStockAlerts1 $DRRX Setting up for a multi day run April 3rd 2019, 2:04pm |
 |
@Ultra_Calls $DRRX 450K block buy April 3rd 2019, 1:04pm |
 |
@TranscriptDaily Short Interest in DURECT Co. $DRRX Declines By 42.1% https://t.co/mqsIaYOe6u April 2nd 2019, 1:04am |
 |
@ThisLincolnian Zacks: Brokerages Anticipate DURECT Co. $DRRX Will Announce Earnings of -$0.05 Per Share https://t.co/AywYLRxcmJ April 1st 2019, 7:04pm |
 |
@StockNewsNow $DRRX DURECT to Present at the H.C. Wainwright Global Life Sciences Conference and Host an Upcoming KOL call on NASH https://t.co/hcCSv2bRAs April 1st 2019, 12:04pm |
 |
@Allstocknews $DRRX DURECT to Present at the H.C. Wainwright Global Life Sciences Conference and Host an Upcoming KOL call From our Stock News Alerts App April 1st 2019, 8:04am |
 |
@bbnsnews DURECT Co. $DRRX Short Interest Update https://t.co/cBhCZDmbIT April 1st 2019, 1:04am |
|
@LlcBillionaire $DRRX under the 50 MA March 31st 2019, 3:03pm |
|
@dakotafinancial DURECT Co. $DRRX Short Interest Down 42.1% in March https://t.co/IeU5rMXdiw March 31st 2019, 2:03am |
|
@AmericanBanking DURECT Co. $DRRX Short Interest Down 42.1% in March https://t.co/6IGIWZOKJt #stocks March 31st 2019, 2:03am |
|
@bibeypost_stock Institutional Investor Sentiment About Durect Corp $DRRX Up https://t.co/1wUc2ffjTm March 31st 2019, 1:03am |
 |
@reurope_stock Durect Corp $DRRX Institutional Investors Sentiment Index Crashed in Q4 2018 https://t.co/LJHtXUNUCs March 31st 2019, 1:03am |
|
@reurope_stock Durect Corporation $DRRX Just Reported Increased Shorts https://t.co/gtZgbjunr1 March 30th 2019, 4:03pm |
|
@bbnsnews DURECT Co. $DRRX Expected to Announce Earnings of -$0.05 Per Share https://t.co/z0g1yzVhjn March 30th 2019, 1:03pm |
|
@ConsumerFeed $3.50 Million in Sales Expected for DURECT Co. $DRRX This Quarter https://t.co/o32Ebm1JXO March 30th 2019, 1:03pm |
|
@4thQuarterCap Added to $DRRX in crockpot March 29th 2019, 4:03pm |
 |
@ZolmaxNews Zacks: Brokerages Expect DURECT Co. $DRRX Will Post Earnings of -$0.05 Per Share https://t.co/TuDef4cjGl March 28th 2019, 9:03am |
 |
@MaisaCorp $DRRX Starts Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 for Non-Alcoholic Steatohepatitis March 27th 2019, 4:03pm |
 |
@LifeSciAdvisors DURECT $DRRX Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alcoholic… https://t.co/grJL3nHzbP March 27th 2019, 3:03pm |
|
@StockNewsNow $DRRX DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alcoholic… https://t.co/U5pvEFsEu9 March 27th 2019, 10:03am |
 |
@newswelldone $DRRX: DURECT begins enrollment in phase 1b trial of oral DUR-928: https://t.co/lnpw30l06C March 27th 2019, 9:03am |
 |
@MarketCurrents $DRRX - DURECT begins enrollment in phase 1b trial of oral DUR-928 https://t.co/bQHhBksAcd March 27th 2019, 9:03am |
 |
@Stock_News_Now $DRRX: New SEC Filing for DRRX: Form 8-K (No. 0001564590-19-009470): https://t.co/kIxFh5LhPF March 27th 2019, 9:03am |
 |
@StockTexts $DRRX DURECT Corporation SEC Filing: Form 8-K https://t.co/apbd4pyI2O March 27th 2019, 9:03am |
 |
@bmarckxCFA $DRRX DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with N...… https://t.co/EK58KBbA0c March 27th 2019, 8:03am |
 |
@ProTradersNews $DRRX: DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of …: https://t.co/aFCnVSimcp March 27th 2019, 8:03am |
|
@Allstocknews $DRRX DURECT Announces Patient Enrollment in Phase 1b Clinical Trial of Oral DUR-928 in Patients with Non-Alc From our Stock News Alerts App March 27th 2019, 8:03am |
|
@AmericanBanking DURECT Co. $DRRX Expected to Post Quarterly Sales of $3.50 Million https://t.co/JuovKLMBtH #stocks March 27th 2019, 3:03am |
 |
@dispatchtribune DURECT Co. $DRRX Expected to Post Quarterly Sales of $3.50 Million https://t.co/uTbmUbunyp March 27th 2019, 3:03am |
|
@AmericanBanking DURECT Co. $DRRX Expected to Announce Earnings of -$0.05 Per Share https://t.co/dtVl4iEGnM #stocks March 25th 2019, 2:03pm |
 |
@registrarjourn Analysts Anticipate DURECT Co. $DRRX Will Announce Earnings of -$0.05 Per Share https://t.co/24Wst9mkjQ March 25th 2019, 2:03pm |
 |
@EnterpriseLeade Analysts Anticipate DURECT Co. $DRRX Will Announce Earnings of -$0.05 Per Share https://t.co/1pYM2HBE5G March 25th 2019, 2:03pm |
 |
@biostockguru $PTIE Non news re: $DRRX - it’s all about novel #alzheimer molecule - expect PR soon March 25th 2019, 9:03am |
|
@LlcBillionaire $DRRX watching the 50 MA here to see if it holds https://t.co/To30hjvgrO March 24th 2019, 7:03pm |
|
@MaisaCorp $PTIE Pain Therapeutics Says Sent Letter To Durect Corp Pursuant To Development And License Agreement $DRRX LE… https://t.co/luXOsbKuhq March 22nd 2019, 7:03pm |
 |
@BioStocks RT @TraderTexMex: $PTIE Pain Therapeutics ends development of REMOXY ER and contractual relationship with Durect Corporation $DRRX March 22nd 2019, 7:03pm |
 |
@TraderTexMex $PTIE Pain Therapeutics ends development of REMOXY ER and contractual relationship with Durect Corporation $DRRX March 22nd 2019, 7:03pm |
 |
@confcalltran Termination of a Material Definitive https://t.co/NnzhMKsPFu $DRRX March 22nd 2019, 4:03pm |
|
@bibeypost_stock Durect Corporation $DRRX Could Burn Your Long Portfolio After More Shorts https://t.co/wPTBnlFOLV March 22nd 2019, 9:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.